Thomas Richard Wenkart serves as Executive at Targeted Medical Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Thomas Richard Wenkart has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 4, 2016 involved receiving (via award) 200,000 shares valued at $10.0K.
Thomas Richard Wenkart currently holds 200,000 shares of Targeted Medical Pharma, Inc. (TRGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Richard Wenkart has been a net neutral trader of TRGM stock. They have purchased $0 and sold $0 worth of shares.
Thomas Richard Wenkart's most recent insider trade was on Mar 4, 2016, when they sold 200,000 shares at $0.05 per share.
Get notified when new Form 4 filings are submitted
| $0.30 |
| Discretionary |
| Jun 30, 2015 | TRGM | $12.1K | Award | 40,183 | $0.30 | Discretionary |